Wells Fargo raised the firm’s price target on Insulet (PODD) to $360 from $350 and keeps an Overweight rating on the shares. The firm notes the company posted a strong Q3 sales/EPS beat and raised FY25 guidance by more than 2-times the beat, mainly on U.S. growth.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD: